default author photo

Joël Guigay

Centre Antoine Lacassagne - Department of Medical Oncology

Nice

France

SCHOLARLY PAPERS

2

DOWNLOADS

281

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Hypofractionated Split-Course Versus Standard Radiotherapy in Frail Elderly Patients with Head and Neck Squamous-Cell Carcinoma (ELAN-RT): A Multicenter, Open-Label, Randomized, Non-Inferiority GORTEC Trial

Number of pages: 35 Posted: 11 Mar 2025
Centre Hospitalier Princesse Grâce, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Gustave Roussy, Institut de Cancérologie de Lorraine, Victor Hugo Clinic, Centre Jean Bernard, Centre Hospitalier de Bretagne Sud, Centre Val d'Aurelle, Centre Antoine Lacassagne, Centre Léon Berard, Sorbonnes Université - Hôpital Tenon, University of Versailles - Ambroise Paré Hospital, Centre de Recherche en Cancérologie de Lyon, Centre de Radiothérapie Saint-Louis Croix-Rouge française, University of Montpellier - Institut de Cancérologie de Montpellier, University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), Centre Guillaume le Conquérant, Forcilles Hospital, Institut de Cancérologie de l'Ouest, Centre Paul Papin, Hôpital Saint-André, Sainte Catherine Institute, Bretonneau University Hospital of Tours, Gustave Roussy, Gustave Roussy, Bergonié Institute, Hospital Center De Saint Brieuc, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Centre Antoine Lacassagne - Department of Medical Oncology and Centre Hospitalier Belfort Montbéliard
Downloads 170 (442,467)

Abstract:

Loading...

Elderly, Head and neck carcinoma, radiotherapy, Hypofractionation, Split course

2.

Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial

Number of pages: 31 Posted: 05 Oct 2020
Centre Antoine Lacassagne - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University of Claude Bernard Lyon 1 - Medical Oncology Department, Centre Antoine Lacassagne, ILC Centre Jean Bernard/Clinique Victor Hugo - Department of Medical Oncology, Institut Català de Oncologia - Department of Medical Oncology, Institut de Cancérologie de Lorraine - Department of Medical Oncology, Clinique des Ormeaux - Department of Medical Oncology, Institut de Cancérologie de l’Ouest Paul Papin - Department of Medical Oncology, Institut de Cancérologie de Montpellier - Department of Medical Oncology, Hôpital Privé le Confluent - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, Centre Antoine Lacassagne - Department of Medical Oncology, Centre François Baclesse - Department of Medical Oncology, Gustave Roussy - Department of Head and Neck Oncology, Centre Hospitalier de Bretagne Sud - Department of Medical Oncology, Hôpital de la Croix Rousse - Department of Medical Oncology, Université de Poitiers - Medical Oncology Department, Institut Claudius Regaud - Department of Medical Oncology, Centre Eugène Marquis - Department of Medical Oncology, Centre Georges-François Leclerc - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Charité Comprehensive Cancer Center, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Autonomous University of Barcelona - Medical Oncology Department and Independent
Downloads 111 (635,507)

Abstract:

Loading...

head and neck cancer, squamous cell carcinoma, recurrent, metastatic, Chemotherapy, cetuximab, taxane.